The following post is from Federal Agency Weekly. It tracks federal grants policy issuances, rulemakings, guidance development and OIG reports and publications. The primary focus of Federal Agency Weekly is agency-wide grants management issues related to extramural research grants from NIH, NSF, NASA, and DOD, though broader coverage of NIH is provided with the inclusion of NIH program activities.
April 6-April 10, 2020
Discover Grants Management Webinars from Thompson Grants See upcoming schedule › |
National Institutes of Health
- Enhancement: Two Factor Authentication Login Option Coming to eRA Modules
- NIH Moving Ahead with FORMS-F Grant Application Form Update (NIH Staff)
- Can ESI Status Be Extended Due to Disruptions From COVID-19? (NIH Staff)
- Some Thoughts on Cybersecurity – Part 1 (Mike Lauer)
- Accessing eRA Modules via login.gov (video)
- What to Do If You Already Have a login.gov Account (video)
- What to Do When You Want to Switch To A Different login.gov Account (video)
- NIH Grants Administration Take 5: Notices of Special Interest (NOSIs) (video)
- Update on COVID-19 Flexibilities for the Research Community (video)
- Policy Notices
- NOT-HS-20-010: Flexibilities Available to AHRQ Recipients and Applicants Directly Impacted by the Novel Coronavirus (COVID-19) Due to Loss of Operations
- NOT-OD-20-090: Reminder: Changes to Forms and Instructions for Research Training Grant, Fellowship, and Career Development Award Applications for Applications Due on or After May 25, 2020
- General Notices
- NOT-CA-20-047: Revised and Corrected Notice on Policy Regarding Minimum Level of Effort for NCI-Funded Awards
- NOT-GM-20-026: Guidance for Cost-Related Flexibilities Available to Support of Competitive Research (SCORE) Award Recipients Affected by COVID-19
- NOT-HG-20-035: Notice of NHGRI Interest in Receiving Letters Requesting Permission to Submit Applications to Support the NHGRI Research Training and Career Development Annual Meeting (U13)
- NOT-HL-20-759: NHLBI Announces Availability of Frequently Asked Questions (FAQs) for NOT-HL-20-757, Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
- NOT-HL-20-780: NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-21-009, Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional)
- NOT-TR-20-019: Notice of Information: Change in NCATS Prior Approval Process for New CTSA Program Pilot Projects that Involve Human Subjects Research
- Changes to Funding Opportunities
- NOT-AG-20-023: Notice to Extend the Expiration Date for RFA-AG-21-016 “Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional)”
- NOT-AG-20-024: Notice to Extend the Expiration Date for PA-18-502 “Advancing the Science of Geriatric Palliative Care (R01 – Clinical Trial Optional)”
- NOT-AG-20-025: Notice to Extend the Expiration Date for PA-18-503 “Advancing the Science of Geriatric Palliative Care (R21 – Clinical Trial Optional)”
- NOT-CA-20-046: Notice of Expiration of RFA-CA-19-046 “Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)
- NOT-FD-20-025: Notice of Change to the Application Due Date and correct Section II Award Information – Award Budget for RFA-FD-20-030 “Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01 Clinical Trials Optional”
- NOT-OD-20-093: Notice of An Additional Cycle of Receipt Dates Added to PAR-18-307 Developing Interventions for Health-Enhancing Physical Activity (R21/R33 – Clinical Trial Optional)
- NOT-TR-20-013: Notice of NCATS’ Participation in PA-20-135 “Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)”
- NOT-TR-20-020: Notice of NCATS Withdrawal from Participation in PAR-18-691, “Innovative Therapies and Tools for Screenable Disorders in Newborns (R21 Clinical Trial Optional)
- Notices of Intent to Publish
- NOT-AA-20-005: Notice of Intent to Publish a Funding Opportunity Announcement for Alcohol-HIV/AIDS Program Project Comorbidities, Coinfections, and Complications Research: Intervention and Cross-Cutting Foundational Research (P01 Clinical Trial Optional)
- NOT-AA-20-006: Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Partnership between on Alcohol Research Centers and Institutions serving Underserved Communities and Populations (U54 Clinical Trial Optional)
- Pre-solicitation Notice
- NOT-AI-20-041: Pre-Solicitation Notice: Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents, RFP: 75N93019R00023
- NOT-AI-20-042: Pre-Solicitation Notice: Immunology Quality Assessment (IQA) Program, RFP: 75N93020R00007
- Notices of Special Interest
- NOT-CA-20-043: Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)
- NOT-CA-20-044:Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions
- NOT-CA-20-045: Notice of Special Interest (NOSI): Advancing Cancer Data Repositories and Knowledgebases
- NOT-DA-20-046: Notice of Special Interest (NOSI): Neuroimmune Signaling and Function in Substance Use Disorders
- NOT-DC-20-004: Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19)
- NOT-DK-20-018: Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK
- NOT-DK-20-020: Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK’s Mission
- NOT-ES-20-015: Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
- NOT-HD-20-008: Notice of Special Interest: Ancillary Reproductive Health Projects to Existing Large and/or Longitudinal Studies
- NOT-MD-20-019: Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities
- NOT-MH-20-041: Notice of Special Interest (NOSI): Supporting Research Education in High-Priority Intervention and Services Research Areas for Mentoring Networks for Mental Health Research Education and Short Courses for Mental Health Related Research
- NOT-MH-20-047: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus
- NOT-TR-20-014: Notice of Special Interest: Clinical and Translational Science Award (CTSA) Program Administrative Supplements
- NOT-TR-20-016: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
- NOT-TR-20-017: Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
Other HHS Agencies and Offices
- OHRP Issues Guidance for Application of the Human Subjects Protection Regulations to Actions Taken in Response to the COVID-19 Pandemic
- Karen Wehner Named Director of the Division of Education & Integrity
National Science Foundation
- Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)
- Dear Colleague Letter: Cybersecurity Education in the Age of Artificial Intelligence
NASA
- [none posted]
Department of Defense
- [none posted]
Office of Management and Budget
Grants.gov
- [none posted]
Miscellaneous Agencies and Offices
- SAM.gov Will Be Down for Scheduled Maintenance Saturday, 04/11/2020 from 8:00 AM to 2:00 PM
- U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) Implementation of OMB Memorandum M-20-17
- DOE-NNSA Implementation of OMB Memorandum M-20-17
- What They Are Saying: Public Officials and Stakeholders Voice Support for EPA’s Discretion Policy for COVID-19 Pandemic
- Department of Energy Announces $38 Million to Support Hydrokinetic Turbine Technology Development
- Department of Energy Announces $30 Million for Machine Learning and Artificial Intelligence Research
- Department of Energy Announces $32 Million for Lower-Cost Fusion Concepts
- NIH Has Acted to Protect Confidential Information Handled by Peer Reviewers, but It Could Do More
- 4/8/20 FR: Information Collection Request Submittal to OMB for Review and Approval; Comment Request; Evaluating End User Satisfaction of EPA’s Research Products (New)
Federal Agency Weekly is an email transmitted on Friday afternoons to subscribers to MANAGING FEDERAL GRANTS for Colleges and Universities. It tracks federal grants policy issuances, rulemakings, guidance development and OIG reports and publications. The primary focus of Federal Agency Weekly is agency-wide grants management issues related to extramural research grants from NIH, NSF, NASA, and DOD, though broader coverage of NIH is provided with the inclusion of NIH program activities. In general, the specifics of individual funding opportunities are not covered.